Created by Guardant Health, the blood test, known as Shield, was able to detect 83% of colorectal cancers in studies but only 13% of dangerous polyps. Colonoscopies find approximately 95% of these ...
Venlo, the Netherlands, Oct. 04, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of its QuantiFERON-EBV RUO (Research Use Only) assay.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback